Brimonidine for managing ocular hypertension and glaucoma

Article

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension, from the December 2008 issue of Clinical Ophthalmology.

Please click here to read the abstract.

Related Videos
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Colman Cawe, director of fundraising and communications, Orbis UK
Greg Kunst, CEO of Aurion Biotech
Related Content
© 2023 MJH Life Sciences

All rights reserved.